September 28, 2020
Business News

Forendo Pharma Appoints Dr Cristina Csimma as Chair of the Board of Directors


TURKU, Finland–()–Forendo Pharma, a clinical-stage drug development company focusing on novel treatments in women’s health, today announced that Dr Cristina Csimma has been appointed as Chair of the Board of Directors. Cristina brings with her deep expertise in the biopharmaceutical, venture capital, and academic sectors.

Commenting on the appointment, Risto Lammintausta, Chief Executive Officer of Forendo Pharma said: “Cristina’s extensive experience at the intersection of areas of global drug development and value creation in biotechnology companies makes her an invaluable addition to the Forendo team as we advance our lead compound towards clinical proof-of-concept in endometriosis patients. I am…



Click here to view the original article.

Related Posts

You might also like ...

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Genius Brands International, Inc. and Encourages Investors to Contact the Firm Before October 19, 2020
AON Splash Image
nVent Announces Quarterly Cash Dividend
Mavenir Adquiere Ip.access para Expandir la Cartera de Radios OpenRAN para CSP y Redes Empresariales Privadas